Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$65.1M |
| 2 |
Procter & Gamble
PG
|
+$55.8M |
| 3 |
Aptiv
APTV
|
+$52.2M |
| 4 |
Stanley Black & Decker
SWK
|
+$50.9M |
| 5 |
General Dynamics
GD
|
+$49.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$46.8M |
| 2 |
Lam Research
LRCX
|
+$46.2M |
| 3 |
Lowe's Companies
LOW
|
+$45.3M |
| 4 |
Royal Caribbean
RCL
|
+$40.3M |
| 5 |
Coca-Cola
KO
|
+$38.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.01% |
| 2 | Technology | 19.39% |
| 3 | Consumer Discretionary | 16.67% |
| 4 | Healthcare | 13.78% |
| 5 | Consumer Staples | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amazon
AMZN
$2.79T
| $42.4M | 0.59% |
586,480
+70,720
| +14% | +$5.06M |
|
27
Labcorp
LH
$27.3B
| $42.2M | 0.59% |
303,433
+182,617
| +151% | +$26.8M |
|
28
AbbVie
ABBV
$468B
| $42.1M | 0.59% |
444,814
+205,570
| +86% | +$22.6M |
|
29
Gilead Sciences
GILD
$181B
| $40.5M | 0.57% |
537,302
-127,490
| -19% | -$10.1M |
|
30
Merck
MRK
$376B
| $40.4M | 0.57% |
778,112
+27,421
| +4% | +$1.48M |
|
31
Emerson Electric
EMR
$87.7B
| $39.5M | 0.55% |
578,200
+554,837
| +2,375% | +$39.5M |
|
32
PepsiCo
PEP
$196B
| $39.5M | 0.55% |
361,728
+213,628
| +144% | +$24.3M |
|
33
General Motors
GM
$77.2B
| $39.3M | 0.55% |
1,082,208
-352,476
| -25% | -$14.3M |
|
34
Yum! Brands
YUM
$41.8B
| $39.3M | 0.55% |
461,839
+110,545
| +31% | +$9.06M |
|
|
TFCFA
35
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $36.2M | 0.51% |
986,408
-565,626
| -36% | -$20.9M |
|
36
Abbott
ABT
$202B
| $36M | 0.5% |
600,639
-256,844
| -30% | -$15.5M |
|
|
CELG
37
DELISTED
Celgene Corp
CELG
| $34.7M | 0.49% |
388,970
+188,036
| +94% | +$18.1M |
|
38
Motorola Solutions
MSI
$79.5B
| $34.6M | 0.48% |
328,115
+255,382
| +351% | +$26.1M |
|
39
DXC Technology
DXC
$1.73B
| $34.5M | 0.48% |
396,876
+386,095
| +3,581% | +$33.8M |
|
40
Medtronic
MDT
$119B
| $34.3M | 0.48% |
427,957
+223,685
| +110% | +$18.5M |
|
41
HP
HPQ
$27.2B
| $33.8M | 0.47% |
1,540,240
-1,260,051
| -45% | -$28.5M |
|
42
General Mills
GIS
$21.4B
| $33.7M | 0.47% |
748,885
+423,837
| +130% | +$23M |
|
43
Accenture
ACN
$113B
| $33.4M | 0.47% |
217,693
+106,060
| +95% | +$16.8M |
|
44
Oracle
ORCL
$422B
| $33M | 0.46% |
721,488
-96,410
| -12% | -$4.79M |
|
45
Qualcomm
QCOM
$169B
| $33M | 0.46% |
595,265
+158,185
| +36% | +$10.1M |
|
46
Westlake Corp
WLK
$10.1B
| $32.5M | 0.45% |
292,387
+36,545
| +14% | +$4.07M |
|
47
Marathon Petroleum
MPC
$101B
| $32.1M | 0.45% |
439,534
+278,804
| +173% | +$19.2M |
|
48
McDonald's
MCD
$192B
| $31.9M | 0.45% |
203,857
+143,562
| +238% | +$23.6M |
|
49
CVS Health
CVS
$119B
| $31.9M | 0.45% |
512,294
-439,502
| -46% | -$31.5M |
|
50
Masco
MAS
$14.5B
| $31.6M | 0.44% |
782,198
+146,505
| +23% | +$6.29M |
|
Similar funds
Joel Greenblatt's Q1 2018 Portfolio in Review
As of Q1 2018, Joel Greenblatt held 1,159 positions worth $7.15B, up 3.8% from $6.89B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Joel Greenblatt deployed $359M of net new capital in Q1 2018, opening 240 new positions and adding to 360 existing holdings. Its largest new stake was IBM: 315,657 shares worth $46.3M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Booking.com, an estimated $46.8M trimmed.
- Joel Greenblatt's largest Q1 2018 buy was IBM: 315,657 shares worth $46.3M.
- Joel Greenblatt added most to Raytheon Company in Q1 2018, an estimated $65.1M increase.
- Joel Greenblatt's biggest Q1 2018 reduction was Booking.com, cutting an estimated $46.8M.
- Joel Greenblatt fully exited Zimmer Biomet in Q1 2018, selling an estimated $37M.
- Joel Greenblatt's ten largest holdings make up 8.8% of its $7.15B portfolio in Q1 2018.
- Joel Greenblatt opened 240 new positions and closed 230 in Q1 2018.
- Joel Greenblatt's portfolio value rose 3.8% quarter-over-quarter to $7.15B.
Based on Gotham Asset Management's 13F filing for Q1 2018, filed 15 May 2018.